 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, March 22, 2006, 26(12):3079-3086; doi:10.1523/JNEUROSCI.3785-05.2006
Previous Article | Next Article
Cellular/Molecular
Neuregulin 1–erbB Signaling Is Necessary for Normal Myelination and Sensory Function
Suzhen Chen,1 Miguel Omar Velardez,1 Xavier Warot,1 Zhao-Xue Yu,1 Shyra J. Miller,3 Didier Cros,2 andGabriel Corfas1 1Division of Neuroscience, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, 2Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, and 3Department of Pediatrics, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 45229-7013
Correspondence should be addressed to Dr. Gabriel Corfas, Division of Neuroscience, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. Email: gabriel.corfas{at}childrens.harvard.edu
To investigate the role of erbB signaling in the interactions between peripheral axons and myelinating Schwann cells, we generated transgenic mice expressing a dominant-negative erbB receptor in these glial cells. Mutant mice have delayed onset of myelination, thinner myelin, shorter internodal length, and smaller axonal caliber in adulthood. Consistent with the morphological defects, transgenic mice also have slower nerve conduction velocity and defects in their responses to mechanical stimulation. Molecular analysis indicates that erbB signaling may contribute to myelin formation by regulating transcription of myelin genes. Analysis of sciatic nerves showed a reduction in the levels of expression of myelin genes in mutant mice. In vitro assays revealed that neuregulin-1 (NRG1) induces expression of myelin protein zero (P0). Furthermore, we found that the effects of NRG1 on P0 expression depend on the NRG1 isoform used. When NRG1 is presented to Schwann cells in the context of cell–cell contact, type III but not type I NRG1 regulates P0 gene expression. These results suggest that disruption of the NRG1–erbB signaling pathway could contribute to the pathogenesis of peripheral neuropathies with hypomyelination and neuropathic pain.
Key words: Schwann cell; myelin protein zero; pain; sciatic nerve; transgenic mouse; neuregulin
Received Sept. 7, 2005; revised Jan. 4, 2006; accepted Feb. 6, 2006.
Correspondence should be addressed to Dr. Gabriel Corfas, Division of Neuroscience, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. Email: gabriel.corfas{at}childrens.harvard.edu
This article has been cited by other articles:
X. Hu, W. He, C. Diaconu, X. Tang, G. J. Kidd, W. B. Macklin, B. D. Trapp, and R. Yan
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
FASEB J, August 1, 2008; 22(8): 2970 - 2980.
[Abstract] [Full Text] [PDF]
Y. Honjo, J. Kniss, and J. S. Eisen
Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons
Development, August 1, 2008; 135(15): 2615 - 2625.
[Abstract] [Full Text] [PDF]
A. I. Flores, S. P. Narayanan, E. N. Morse, H. E. Shick, X. Yin, G. Kidd, R. L. Avila, D. A. Kirschner, and W. B. Macklin
Constitutively Active Akt Induces Enhanced Myelination in the CNS
J. Neurosci., July 9, 2008; 28(28): 7174 - 7183.
[Abstract] [Full Text] [PDF]
Y.-J. J. Chen, M. A. Johnson, M. D. Lieberman, R. E. Goodchild, S. Schobel, N. Lewandowski, G. Rosoklija, R.-C. Liu, J. A. Gingrich, S. Small, et al.
Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components
J. Neurosci., July 2, 2008; 28(27): 6872 - 6883.
[Abstract] [Full Text] [PDF]
M. L. Hancock, S. E. Canetta, L. W. Role, and D. A. Talmage
Presynaptic Type III Neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons
J. Cell Biol., May 1, 2008; 181(3): 511 - 521.
[Abstract] [Full Text] [PDF]
A. V. Savonenko, T. Melnikova, F. M. Laird, K.-A. Stewart, D. L. Price, and P. C. Wong
Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice
PNAS, April 8, 2008; 105(14): 5585 - 5590.
[Abstract] [Full Text] [PDF]
T. C. de Sampaio e Spohr, J. W. Choi, S. E. Gardell, D. R. Herr, S. K. Rehen, F. C. A. Gomes, and J. Chun
Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation
J. Biol. Chem., March 21, 2008; 283(12): 7470 - 7479.
[Abstract] [Full Text] [PDF]
Y. Wen, E. Planel, M. Herman, H. Y. Figueroa, L. Wang, L. Liu, L.-F. Lau, W. H. Yu, and K. E. Duff
Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3{beta} Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing
J. Neurosci., March 5, 2008; 28(10): 2624 - 2632.
[Abstract] [Full Text] [PDF]
R. Perrot, P. Lonchampt, A. C. Peterson, and J. Eyer
Axonal Neurofilaments Control Multiple Fiber Properties But Do Not Influence Structure or Spacing of Nodes of Ranvier
J. Neurosci., September 5, 2007; 27(36): 9573 - 9584.
[Abstract] [Full Text] [PDF]
M. A. Thacker, A. K. Clark, F. Marchand, and S. B. McMahon
Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules
Anesth. Analg., September 1, 2007; 105(3): 838 - 847.
[Abstract] [Full Text] [PDF]
K. Roy, J. C. Murtie, B. F. El-Khodor, N. Edgar, S. P. Sardi, B. M. Hooks, M. Benoit-Marand, C. Chen, H. Moore, P. O'Donnell, et al.
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders
PNAS, May 8, 2007; 104(19): 8131 - 8136.
[Abstract] [Full Text] [PDF]
M. Bjarnadottir, D. L. Misner, S. Haverfield-Gross, S. Bruun, V. G. Helgason, H. Stefansson, A. Sigmundsson, D. R. Firth, B. Nielsen, R. Stefansdottir, et al.
Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/- Knock-Outs Compared with Wild-Type Mice
J. Neurosci., April 25, 2007; 27(17): 4519 - 4529.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|